Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primitive Neuroectodermal Tumors (PNETs)”

248 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 248 results

Early research (Phase 1)Study completedNCT01975116
What this trial is testing

P28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Who this might be right for
Teratoid Tumor, AtypicalChoroid Plexus NeoplasmsAnaplastic Astrocytoma+7 more
Pediatric Brain Tumor Consortium 18
Testing effectiveness (Phase 2)Study completedNCT01326104
What this trial is testing

Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor

Who this might be right for
MedulloblastomaNeuroectodermal Tumor
University of Florida 26
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Not applicableStudy completedNCT00303810
What this trial is testing

Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

Who this might be right for
Brain and Central Nervous System Tumors
Universitätsklinikum Hamburg-Eppendorf 567
Testing effectiveness (Phase 2)Ended earlyNCT00003515
What this trial is testing

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors

Who this might be right for
Primitive Neuroectodermal Tumor
Burzynski Research Institute 1
Early research (Phase 1)Study completedNCT00784914
What this trial is testing

A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
City of Hope Medical Center 12
Early research (Phase 1)UnknownNCT00360854
What this trial is testing

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 48
Large-scale testing (Phase 3)Study completedNCT00085202
What this trial is testing

Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 416
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00609141
What this trial is testing

IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor

Who this might be right for
Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00006102
What this trial is testing

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more
National Cancer Institute (NCI) 200
Early research (Phase 1)Study completedNCT00363272
What this trial is testing

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00003457
What this trial is testing

Antineoplaston Therapy in Treating Patients With Brain Tumors

Who this might be right for
Refractory Brain Tumors
Burzynski Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT00055952
What this trial is testing

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Who this might be right for
Sarcoma
Daiichi Sankyo
Early research (Phase 1)Study completedNCT00004212
What this trial is testing

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Daiichi Sankyo
Early research (Phase 1)Ended earlyNCT00253721
What this trial is testing

Melphalan With BBBD in Treating Patients With Brain Malignancies

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
OHSU Knight Cancer Institute 21
Testing effectiveness (Phase 2)UnknownNCT00281905
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Cancer and Leukaemia Group 50
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Load More Results